SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the appointment of Nishan de Silva, M.D., as Vice President of Corporate Development. In this newly created position, Dr. de Silva will report to President and Chief Executive Officer John Higgins, and focus on corporate strategy, acquisitions and out-licensing.
